Pulmonary Infections
From the Journals
Tofacitinib shows mortality benefit in patients with COVID-19 pneumonia
Feature
Clean indoor air is vital for infection control
From the Journals
Pediatric bronchiolitis: Less is more
With bronchiolitis still the poster disease for low-value interventions, it’s time to retire widely used but ineffective therapies and focus on...
From the Journals
Hospitalization not rare for children with COVID, study says
“Although most children with COVID-19 experience mild illness, some children develop serious illness that leads to hospitalization.”
From the Journals
Prospective data support delaying antibiotics for pediatric respiratory infections
Children who were immediately prescribed antibiotics showed no significant difference in symptom severity or duration from those who received a...
Feature
Arthritis drugs ‘impressive’ for severe COVID but not ‘magic cure’
U.S. and U.K. experts weigh in on research that compares monoclonal antibody therapies with usual care for people critically ill with COVID-19.
From the Journals
COVID-19 symptoms persist months after acute infection
Majority of previously hospitalized patients were experiencing fatigue or muscle weakness 6 months after discharge.
Conference Coverage
Seeking new vaccines against whooping cough: The PERISCOPE project
Conference Coverage
Metapneumovirus infections clinically indistinguishable from flu, RSV
Conference Coverage
Potentially practice-changing bacterial therapy trials analyzed
Feature
Survey: Acceptance of COVID-19 vaccine dips below 50%
Willingness to get such a vaccine has been steadily dropping since April.